Skip to main content

Table 3 ExAC allele frequencies of the 74 hypertrophic cardiomyopathy “gold standard” missense variants

From: Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation

Gene

Variant

Effect

Classification

MAF

MYBPC3

NM_000256.3:c.772G > A

p.Glu258Lys

Pathogenic

0.0039%a

MYH7

NM_000257.2:c.2389G > A

p.Ala797Thr

Pathogenic

0.0033%

MYBPC3

NM_000256.3:c.1504C > T

p.Arg502Trp

Pathogenic

0.0025%

MYH7

NM_000257.2:c.2167C > T

p.Arg723Cys

Pathogenic

0.0025%

TNNI3

NM_000363.4:c.485G > A

p.Arg162Gln

Pathogenic

0.0025%

MYH7

NM_000257.2:c.1988G > A

p.Arg663His

Pathogenic

0.0016%

MYBPC3

NM_000256.3:c.1484G > A

p.Arg495Gln

Pathogenic

0.00083%

MYL2

NM_000432.3:c.173G > A

p.Arg58Gln

Pathogenic

0.00083%

MYL2

NM_000432.3:c.64G > A

p.Glu22Lys

Pathogenic

0.00083%

TNNI3

NM_000363.4:c.433C > T

p.Arg145Trp

Pathogenic

0.00083%

MYH7

NM_000257.2:c.2609G > A

p.Arg870His

Pathogenic

0.00082%b

TNNT2

NM_001001430.1:c.274C > T

p.Arg92Trp

Pathogenic

0.00082%

TNNI3

NM_000363.4:c.433C > G

p.Arg145Gly

Pathogenic

0.00080%

MYBPC3

NM_000256.3:c.1351G > C

p.Glu451Gln

Pathogenic

0

MYBPC3

NM_000256.3:c.1505G > A

p.Arg502Gln

Pathogenic

0

MYBPC3

NM_000256.3:c.2265C > A

p.Asn755Lys

Pathogenic

0

MYH7

NM_000257.2:c.1207C > T

p.Arg403Trp

Pathogenic

0

MYH7

NM_000257.2:c.1208G > A

p.Arg403Gln

Pathogenic

0

MYH7

NM_000257.2:c.1357C > T

p.Arg453Cys

Pathogenic

0

MYH7

NM_000257.2:c.1750G > C

p.Gly584Arg

Pathogenic

0

MYH7

NM_000257.2:c.1816G > A

p.Val606Met

Pathogenic

0

MYH7

NM_000257.2:c.2146G > A

p.Gly716Arg

Pathogenic

0

MYH7

NM_000257.2:c.2155C > T

p.Arg719Trp

Pathogenic

0

MYH7

NM_000257.2:c.2156G > A

p.Arg719Gln

Pathogenic

0

MYH7

NM_000257.2:c.2167C > G

p.Arg723Gly

Pathogenic

0

MYH7

NM_000257.2:c.2221G > T

p.Gly741Trp

Pathogenic

0

MYH7

NM_000257.2:c.2717A > G

p.Asp906Gly

Pathogenic

0

MYH7

NM_000257.2:c.2722C > G

p.Leu908Val

Pathogenic

0

MYH7

NM_000257.2:c.2770G > A

p.Glu924Lys

Pathogenic

0

MYH7

NM_000257.2:c.2788G > A

p.Glu930Lys

Pathogenic

0

MYH7

NM_000257.2:c.4135G > A

p.Ala1379Thr

Pathogenic

0

MYH7

NM_000257.2:c.438G > T

p.Lys146Asn

Pathogenic

0

MYH7

NM_000257.2:c.767G > A

p.Gly256Glu

Pathogenic

0

TNNI3

NM_000363.4:c.470C > T

p.Ala157Val

Pathogenic

0

TNNI3

NM_000363.4:c.557G > A

p.Arg186Gln

Pathogenic

0

TNNI3

NM_000363.4:c.575G > A

p.Arg192His

Pathogenic

0

TNNT2

NM_001001430.1:c.236 T > A

p.Ile79Asn

Pathogenic

0

TNNT2

NM_001001430.1:c.275G > A

p.Arg92Gln

Pathogenic

0

TNNT2

NM_001001430.1:c.421C > T

p.Arg141Trp

Pathogenic

0

TPM1

NM_000366.5:c.523G > A

p.Asp175Asn

Pathogenic

0

TPM1

NM_000366.5:c.688G > A

p.Asp230Asn

Pathogenic

0

MYBPC3

NM_000256.3:c.2686G > A

p.Val896Met

Likely benign

1.28%a

MYBPC3

NM_000256.3:c.833G > A

p.Gly278Glu

Likely benign

0.29%a

TNNI3

NM_000363.4:c.244C > T

p.Pro82Ser

Likely benign

0.28%

MYBPC3

NM_000256.3:c.565G > A

p.Val189Ile

Likely benign

0.27%

MYBPC3

NM_000256.3:c.3413G > A

p.Arg1138His

Likely benign

0.13%

MYBPC3

NM_000256.3:c.1519G > A

p.Gly507Arg

Likely benign

0.068%

MYBPC3

NM_000256.3:c.3004C > T

p.Arg1002Trp

Likely benign

0.067%

TNNI3

NM_000363.4:c.235C > T

p.Arg79Cys

Likely benign

0.043%

MYBPC3

NM_000256.3:c.1564G > A

p.Ala522Thr

Likely benign

0.039%

MYBPC3

NM_000256.3:c.440C > T

p.Pro147Leu

Likely benign

0.038%a

MYH7

NM_000257.2:c.3981C > A

p.Asn1327Lys

Likely benign

0.010%

MYBPC3

NM_000256.3:c.1147C > G

p.Leu383Val

Likely benign

0.0089%

MYBPC3

NM_000256.3:c.842G > A

p.Arg281Gln

Likely benign

0.0070%a

MYBPC3

NM_000256.3:c.1633C > A

p.Leu545Met

Likely benign

0.0034%

MYBPC3

NM_000256.3:c.1246G > A

p.Gly416Ser

Likely benign

0.0029%

MYBPC3

NM_000256.3:c.2063C > A

p.Thr688Lys

Likely benign

0.0019%a

MYBPC3

NM_000256.3:c.3142C > T

p.Arg1048Cys

Likely benign

0.0017%

TNNT2

NM_001001430.1:c.805A > T

p.Asn269Tyr

Likely benign

0.0017%a

MYBPC3

NM_000256.3:c.2410C > A

p.Leu804Met

Likely benign

0

MYH7

NM_000257.2:c.321 T > G

p.Asp107Glu

Likely benign

0

MYH7

NM_000257.2:c.4555A > T

p.Ser1519Cys

Likely benign

0

MYH7

NM_000257.2:c.8A > C

p.Asp3Ala

Likely benign

0

TNNI3

NM_000363.4:c.244C > A

p.Pro82Thr

Likely benign

0

TNNI3

NM_000363.4:c.253 T > A

p.Leu85Met

Likely benign

0

TNNI3

NM_000363.4:c.257C > A

p.Ala86Asp

Likely benign

0

TNNT2

NM_001001430.1:c.682C > G

p.Gln228Glu

Likely benign

0

MYBPC3

NM_000256.3:c.706A > G

p.Ser236Gly

Benign

10.79%

MYBPC3

NM_000256.3:c.472G > A

p.Val158Met

Benign

9.04%a

TNNT2

NM_001001430.1:c.758A > G

p.Lys253Arg

Benign

5.07%

MYH7

NM_000257.2:c.4472C > G

p.Ser1491Cys

Benign

0.75%

MYBPC3

NM_000256.3:c.977G > A

p.Arg326Gln

Benign

0.55%

MYBPC3

NM_000256.3:c.1144C > T

p.Arg382Trp

Benign

0.42%

MYBPC3

NM_000256.3:c.2498C > T

p.Ala833Val

Benign

0.22%

  1. Jordan et al. [28] previously published a curated list of 74 “gold standard” missense variants in genes associated with hypertrophic cardiomyopathy. All pathogenic variants were observed at allele frequencies of less than 0.005% in the ExAC dataset
  2. aLoci covered by less than 80,000 total alleles in ExAC
  3. bA variant that did not pass the variant calling quality filter in ExAC